Home › Companies › NRXP

NRX Pharmaceuticals

NRXP Rare disease Lead: NDA Submitted 15 Biotech Distilled articles ↓

Neurology Small Molecule

Most recent annual filing: 2026-03-23

Catalyst timeline

4 trackedQuarter catalyst calendar →

NRX-101 Ph3 start2026NRX-101 Ph3 start, 2026, routine
SPARC-TMS TMS trial start4Q 2026SPARC-TMS TMS trial start, 4Q 2026, routine
Corporate financials filingNov 2026Corporate financials filing, Nov 2026, notable
NRX-100 ANDA FDA decisionNov 10, 2026NRX-100 ANDA FDA decision, Nov 10, 2026, thesis-defining

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.

Pipeline (6 active programs)

KETAFREE

ketamine · preservative-free ketamine · NRX-100

Small Molecule Target: NMDA receptor

Suicidal Ideation in Depression NDA Submitted intravenous NCT03396601

D-cycloserine

lurasidone · D-cycloserine/lurasidone · NRX-101

Small Molecule Target: NMDA receptor, NMDA

Bipolar Depression NDA Submitted oral NCT02974010
Major Depressive Disorder oral

D-cycloserine

NRX-101

PTSD Preclinical oral Zeta Surgical

D-cycloserine/lurasidone fixed dose combination

NRX-101

Treatment-Resistant Major Depressive Disorder Phase 1 oral NCT05779267

GNK-301

Target: HERV-K envelope protein, K Env

Amyotrophic Lateral Sclerosis

Technology platforms

NMDA platform

NMDA receptor-targeting platform for central nervous system disorders including suicidal depression, chronic pain, and PTSD

Targets: NMDA

Biotech Distilled coverage (15)

2026-10-01 UPDATE: NRx Pharmaceuticals (NRXP) - The Contract Number Arrives 🔒 Paid
2026-09-16 UPDATE: NRx Pharmaceuticals (NRXP) - Major Becomes Minor, and the Clock Gets a Date 🔒 Paid
2026-08-15 UPDATE: NRx Pharmaceuticals (NRXP) - The ATM Never Went Dormant 🔒 Paid
2026-08-08 UPDATE: NRx Pharmaceuticals (NRXP) - The Cap, Not the Compound 🔒 Paid
2026-07-22 UPDATE: NRx Pharmaceuticals (NRXP) - DARPA Picks Up the Phone 🔒 Paid
2026-06-24 UPDATE: NRx Pharmaceuticals (NRXP) - Kadima Sues, Zeta Goes Live 🔒 Paid
2026-06-03 UPDATE: NRx Pharmaceuticals (NRXP) - The Print Lands at $3.50
2026-06-02 UPDATE: NRx Pharmaceuticals (NRXP) - The Underwritten Raise Finally Prints
2026-05-16 UPDATE: NRx Pharmaceuticals (NRXP) - The ATM Receipts Arrive (And a Swiss Surprise) 🔒 Paid
2026-05-08 UPDATE: NRx Pharmaceuticals (NRXP) - The Fertilizer Trial Gets a Green Light 🔒 Paid
2026-04-27 UPDATE: NRx Pharmaceuticals (NRXP) - The Hail Mary Becomes a Layup 🔒 Paid
2026-03-28 UPDATE: NRX Pharmaceuticals - The 10-K Drops, The ATM Spins, and the Evergreen Grab Passes 🔒 Paid
2026-03-21 UPDATE: NRX Pharmaceuticals (NRXP) - The FDA Blinks... 🔒 Paid
2026-02-14 UPDATE: NRx Pharmaceuticals (NRXP) — The Proxy Drops (And the Math is Ugly) 🔒 Paid
2026-01-13 NRx Pharmaceuticals (NRXP): Scientific Deep Dive for KETAFREE™ 🔒 Paid

Articles open on Substack. Some are subscriber-only; those marked ★ Distilled Pro are for Distilled Pro members.